PMDA drug package insert
ラナンキュラスぢ坐剤Ａ
PMDA OTC drug · 奥田製薬（株） · package insert Jul 17, 2024
Key facts
| Brand names | ラナンキュラスぢ坐剤Ａ |
|---|---|
| Companies | 製造販売元／奥田製薬（株）,販売会社／奥田製薬（株） |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 挿入剤 |
| OTC effect category | 外用痔疾用薬 |
| Package insert date | Jul 17, 2024 |
| PMDA document key | 180150_J1501000247 |
| PMDA company code | 180150 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: